Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

NCT00454337 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: FTC/TDF + EFV or LPV/R +T20
DRUG: FTC/TDF + EFV or LPV/R

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]